HOME >> MEDICINE >> NEWS
LA BioMed Medical/Research Briefs December 2004

Men with chronic obstructive pulmonary disease (COPD) -- which includes a number of lung problems such as emphysema that make breathing difficult -- may benefit from an extra dose of testosterone, a new study indicates.

People with COPD are often easily fatigued and can't tolerate much physical exertion, probably because of loss of muscle strength. Testosterone supplementation appears to increase lean muscle mass and strength in men with moderate to severe COPD and low testosterone levels, LA BioMed researchers report in the American Journal of Respiratory and Critical Care Medicine.

"Patients with chronic lung disease have been found to benefit from rehabilitative therapies aimed at improving the function of their muscles. This research suggests the anabolic drug testosterone improves muscle strength," says Dr. Richard Casaburi. Casaburi and colleagues investigated the effects of testosterone supplementation in a study of 47 men with COPD and low normal testosterone levels.

The participants were randomly assigned to one of four treatment groups: testosterone supplementation and strength training; placebo and strength training; testosterone and no strength training; or placebo and no strength training. After 10 weeks, both testosterone groups showed a significant increase in lean body mass. This amounted to an average increase of 2.3 kilograms (about 5 pounds) in those given testosterone alone and 3.3 kg (a little more than 7 pounds) in those who received training and testosterone.

Moreover, the team found that maximum leg press strength increased 17 percent with either testosterone alone or training alone, but by 27 percent with both. No adverse effects were seen. Despite these encouraging results, "further research in a larger number of patients is needed before we can routinely recommend testosterone supplementation for men with COPD," Casaburi cautioned.

To contact Dr. Casaburi, please call David Feuerherd at 310-2
'"/>

Contact: David Feuerherd
df@issuesmanagement.com
310-215-0234
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
22-Nov-2004


Page: 1 2 3

Related medicine news :

1. LA BioMed medical/research briefs March 2005
2. LA BioMed medical/research briefs January 2005
3. LA BioMed Medical/Research briefs January 2005
4. LA BioMed research briefs
5. BioMed Central -- freedom of information for the science community
6. American Thoracic Society Journal news tips for December 2004 (second issue)
7. Other highlights in the December 15 JNCI
8. News briefs from the Journal CHEST, December 2004
9. December 2004 Ophthalmology journal
10. November/December 2004 Annals of Family Medicine tip sheet
11. American Thoracic Socety journal news tips for December 2004 (first issue)

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: BioMed Medical Research Briefs December

(Date:6/18/2013)... (PRWEB) June 19, 2013 Looking for a ... monotony of everyday life? , IWALKAWAKE is a guide ... Written by Adam Botha, it focuses on harnessing the powerful ... The book lays out a nine-step guide to finding one’s ... that a person must go through to reach their true ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its readers entertained ... , The magazine has decided to prepare readers for the ... recipe every week . , According to Daily Gossip ... readers who are looking to get insights into this type ... anabolic food is almost entirely based on healthy, yet tasteful ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 SEATTLE, WA—A ... Farms of Fairview, Oregon, claiming he fell ill with ... berry and pomegranate seed blend. The complaint was ... by Marler Clark, the Seattle-based law firm that has ... , According to the complaint, Brian Brothers consumed “Townsend ...
(Date:6/18/2013)... Warner, NH (PRWEB) June 18, 2013 ... rugged, submersible, battery powered, stand-alone device which can be ... The new stainless steel enclosure of the Temp1000IS comes ... device interfaces with the IFC400 (sold separately) ... docking station for full communications. No more removal of ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and Taiwan ... first time in the U.S.—the need for more collaboration between ... in a timely manner. Representatives from the Taiwan and mainland ... and processes in drug review during the Convergence in ... DIA 2013 49th Annual Meeting . , While ...
Breaking Medicine News(10 mins):Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... VPII Escrow Corp., a newly formed wholly owned Canadian ... approximately $3.2 billion aggregate principal amount of senior unsecured ... 2021 and in 2023, with final tranching determined at ... net proceeds from the offering, together with proceeds from ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: